Morgan Stanley’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Morgan Stanley’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-93,054	Closed	-$112K	–	8104
2023 Q4	$112K	Buy	93,054 +74,970	+415%	+$80.9K	﹤0.01%	6122
2023 Q3	$15.6K	Sell	18,084 -39,151	-68%	-$42.9K	﹤0.01%	6562
2023 Q2	$68.7K	Buy	57,235 +32,915	+135%	+$165K	﹤0.01%	6093
2023 Q1	$213K	Buy	24,320 +12,033	+98%	+$111K	﹤0.01%	5681
2022 Q4	$98.3K	Buy	12,287 +1,300	+12%	+$8.16K	﹤0.01%	5984
2022 Q3	$53K	Sell	10,987 -7,683	-41%	-$48.2K	﹤0.01%	6387
2022 Q2	$105K	Buy	18,670 +9,953	+114%	+$34.2K	﹤0.01%	6249
2022 Q1	$44K	Buy	8,717 +3,816	+78%	+$30.6K	﹤0.01%	6771
2021 Q4	$63K	Buy	4,901 +3,439	+235%	+$49.1K	﹤0.01%	6701
2021 Q3	$21K	Buy	1,462 +1,069	+272%	+$18.2K	﹤0.01%	7085
2021 Q2	$5K	Buy	+393	New	+$6.89K	﹤0.01%	7407

Morgan Stanley's RAIN Position: Q1 2024 in Review

Morgan Stanley sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 93,054 shares — an estimated $112K sold.

Morgan Stanley first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $213K in Q1 2023. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Morgan Stanley reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Morgan Stanley sold 93,054 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $112K.
Morgan Stanley first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Morgan Stanley's Rain Oncology Inc. Common Stock position peaked at $213K in Q1 2023.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.